A Phase I, Open Label, Randomized, Two Cohort, Two Period, Oneway Study to Evaluate the Effect of Boceprevir and Telaprevir onDolutegravir Pharmacokinetics in Healthy Adult Subjects (ING115697)
Phase of Trial: Phase I
Latest Information Update: 03 Apr 2017
At a glance
- Drugs Boceprevir; Dolutegravir; Telaprevir
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors ViiV Healthcare
- 16 May 2014 Results published in the British Journal of Clinical Pharmacology.
- 01 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Apr 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.